Publication | Year | ||||||||
---|---|---|---|---|---|---|---|---|---|
Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies Authors : rachel riechelmann , axel grotheyVolume : 9 Pages : 106-126 |
2016 | ||||||||
Drug interactions in cancer patients: A hidden risk? Authors : rachel riechelmann , daniel girardiVolume : 5 Pages : 77 |
2016 | ||||||||
The role of regorafenib in metastatic colorectal cancer Authors : rachel riechelmann , axel grotheyVolume : 16 Pages : 596-597 |
2015 |